SOL Capital Management’s Eli Lilly LLY Stock Holding History

SOL Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-755	Closed	-$811K	–	197
2025 Q4	$811K	Hold	755	–	–	0.07%	193
2025 Q3	$576K	Sell	755 -1	-0.1%	-$744	0.05%	218
2025 Q2	$589K	Hold	756	–	–	0.06%	215
2025 Q1	$624K	Hold	756	–	–	0.07%	203
2024 Q4	$584K	Hold	756	–	–	0.07%	207
2024 Q3	$670K	Buy	756 +1	+0.1%	+$899	0.07%	201
2024 Q2	$684K	Buy	755 +335	+80%	+$268K	0.08%	198
2024 Q1	$327K	Sell	420 -30	-7%	-$21.4K	0.04%	254
2023 Q4	$262K	Hold	450	–	–	0.04%	268
2023 Q3	$242K	Hold	450	–	–	0.04%	262
2023 Q2	$211K	Buy	+450	New	+$189K	0.03%	271
2019 Q2	–	Sell	-1,704	Closed	-$221K	–	246
2019 Q1	$221K	Buy	+1,704	New	+$207K	0.06%	229

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SOL Capital Management's LLY Position: Q1 2026 in Review

SOL Capital Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 755 shares — an estimated $811K sold.

SOL Capital Management first reported a position in LLY in Q1 2019 and held it in 12 quarters. The position peaked at $811K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

SOL Capital Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
SOL Capital Management sold 755 Eli Lilly shares in Q1 2026, an estimated $811K.
SOL Capital Management first reported a position in Eli Lilly in Q1 2019 and held it in 12 quarters.
SOL Capital Management's Eli Lilly position peaked at $811K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on SOL Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.